ZenVax is a young biotech with ties to University of Missouri and organized around development of safe, effective, and novel vaccines against microbial pathogens with the long-term goal being development of a safe and effective licensed vaccine against Q fever. With conduct and cmpletion of the project, the intent is then subsequently to attempt to employ the Q fever mimotope vaccine development process as the model to demonstrate that mimotope vaccine technology can be utilized as a broad platform against other bacterial pathogens.
